The invention relates to monitoring a subject, particularly for extracting a frequency of a periodic physiological process such as a respiration rate.
Intelligent monitoring of vital signs (such as heart rate, respiratory rate (RR), blood oxygen saturation level (SpO2) and blood pressure) in unobtrusive ways is desirable to recognize patients at risk of deterioration. Replacement of manual recordings of physiological parameters (which are not always accurate or repeatable) by automated systems is desirable.
Automation of RR measurements while achieving high patient compliance and accuracy has proved challenging. RR is currently measured in hospitals by manual counting of breaths, conventional impedance pneumography (IP) or via an optical technique called end-tidal carbon dioxide (et-CO2). For continuous monitoring of RR, both IP and et-CO2 are subject to limitations in terms of patient compliance and accuracy.
Acceleration signals have been used for many motion analysis applications such as gait, posture, and balance analysis. The use of accelerometers for motion analysis has significantly increased due to their ease of use, portability, and ability to be integrated in low-power wireless embedded platforms. It has been proposed to using acceleration signals to monitor RR.
To estimate respiratory rate based on acceleration signals, a low-pass or band-pass filtering is typically applied to each axis separately. A frequency in the range of 0.05 Hz to 1 Hz with maximum peak amplitude in the spectral domain can then be selected to calculate the breaths per minute (bpm). A number of studies [1], [2], [3], [4] have investigated the estimation of respiratory rate from acceleration signals. A gas pressure system has been used to validate estimation of respiratory rate from accelerometers placed on the subject's sternum [5]. A relative mean error of −0.15 bpm has been reported. In [6], chest worn accelerometers were used to estimate respiratory rate and showed high correlation to flow rate measurements from a nasal cannula. A single chest patch sensor containing ECG and accelerometers has been used in [7] to compare fusion of three respiratory rate estimates, one estimate from accelerometer and two estimates using ECG from respiratory sinus arrhythmia and QRS modulation, to a capnography derived reference [8].
It is an object of the invention to provide improved methods and apparatus for monitoring patients.
According to an aspect of the invention, there is provided a computer-implemented method of monitoring a human or animal subject, comprising: (a) receiving measurement data representing a time series of measurements on a subject performed by a sensor system; (b) processing the measurement data to represent the measurement data as a mathematical expansion comprising a plurality of expansion components and a corresponding plurality of expansion coefficients representing the respective strength of each expansion component; (c1) forming a first partial reconstruction of the measurement data using a first subset of the expansion components and corresponding expansion coefficients; (c2) forming a second partial reconstruction of the measurement data using a second subset of the expansion components and corresponding expansion coefficients, the second subset being different from the first subset; (d1) performing a first spectral analysis on the first partial reconstruction to determine a first dominant frequency, the first dominant frequency representing a frequency component of largest amplitude in the first partial reconstruction; (d2) performing a second spectral analysis on the second partial reconstruction to determine a second dominant frequency, the second dominant frequency representing a frequency component of largest amplitude in the second partial reconstruction; and (e) providing an output representing a frequency of a periodic physiological process based on either or both of the first dominant frequency and the second dominant frequency.
Thus, a method is provided in which dominant frequencies from multiple different partial reconstructions of measurement data are used to provide an output of a frequency of a periodic physiological process. The inventors have found that this approach allows the frequency to be obtained reliably, particularly when the measurement data is contaminated with low-frequency noise that is potentially close to the frequency of the physiological process of interest. In particular, by comparing different dominant frequencies for consistency it is possible to automatically identify situations in which the measurement data will not yield a reliable estimation of the frequency of the periodic physiological process. Output of an estimation using that measurement data can thus be discarded and the method can move on to consider a subsequent segment of measurement data. The number of invalid estimations output in a given measurement period (containing multiple units of the measurement data) can thus be reduced.
In some embodiments, the sensor system comprises one or more accelerometers. The inventors have found that the methodology is particularly beneficial in this context, due to the vulnerability of accelerometers to contamination by low frequency noise, caused for example by movement of a subject being monitored that is not related to the physiological process of interest. The low frequency noise can comprise low frequency edges in the spectra of measurement data, which can be difficult to tell apart from a signal of interest (e.g. RR).
In some embodiments, the frequency of the periodic physiological process comprises a respiration rate (RR). The inventors have found that the methodology is particularly beneficial in this context, particularly where accelerometers are used to provide the measurement data. This is because typical RR frequencies are close or overlap with common low frequency noise components observed when accelerometers are attached to subjects.
The method allows reliable measurements of RR to be achieved using comfortable wearable devices (in contrast to the alternative techniques mentioned in the introductory part of the description, which achieve significantly lower patient compliance). The methodology can be implemented in a computationally efficient manner, which makes it possible for the wearable devices and/or computers with which the wearable devices communicate, to be implemented with minimal computational resources. Sensitivity is high enough to allow accelerometers to be positioned in a variety of locations without compromising the ability to measure RR reliably. This provides greater flexibility for creating wearable devices, facilitates patient comfort and allows accelerometer-based measurements of RR to be made even where it is not possible to position accelerometers on the chest (for example). The method works well for example where accelerometers are worn comfortably on the arm.
The study described below demonstrates the above advantages using real data collected during monitoring of patients following discharge from intensive care units (ICUs). The results of estimated respiratory rate from two different signal modalities (PPG and accelerations) in a continuous long period of time are shown to be in close agreement for many segments of measurement data across patients, despite the fact that the raw signals are severely affected by various motion interferences, sensor fault, and detachment.
According to an alternative aspect of the invention, there is provided an apparatus for monitoring a human or animal subject, comprising: a data receiving unit configured to receive measurement data representing a time series of measurements on a subject performed by a sensor system; a data processing unit configured to: process the measurement data to represent the measurement data as a mathematical expansion comprising a plurality of expansion components and a corresponding plurality of expansion coefficients representing the respective strength of each expansion component; form a first partial reconstruction of the measurement data using a first subset of the expansion components and corresponding expansion coefficients; form a second partial reconstruction of the measurement data using a second subset of the expansion components and corresponding expansion coefficients, the second subset being different from the first subset; perform a first spectral analysis on the first partial reconstruction to determine a first dominant frequency, the first dominant frequency representing a frequency component of largest amplitude in the first partial reconstruction; perform a second spectral analysis on the second partial reconstruction to determine a second dominant frequency, the second dominant frequency representing a frequency component of largest amplitude in the second partial reconstruction; and provide an output representing a frequency of a periodic physiological process based on either or both of the first dominant frequency and the second dominant frequency.
Embodiments of the invention will now be described, by way of example only, with reference to the accompanying drawings in which corresponding reference symbols indicate corresponding parts, and in which:
Methods of the present disclosure are computer-implemented. Each step of the disclosed methods may therefore be performed by a computer. The computer may comprise various combinations of computer hardware, including for example CPUs, RAM, SSDs, motherboards, network connections, firmware, software, and/or other elements known in the art that allow the computer hardware to perform the required computing operations. The required computing operations may be defined by one or more computer programs. The one or more computer programs may be provided in the form of media, optionally non-transitory media, storing computer readable instructions. When the computer readable instructions are read by the computer, the computer performs the required method steps. The computer may consist of a self-contained unit, such as a general-purpose desktop computer, laptop, tablet, mobile telephone, smart device (e.g. smart TV), etc. Alternatively, the computer may consist of a distributed computing system having plural different computers connected to each other via a network such as the internet or an intranet.
The method comprises a step S1 of performing physiological measurements on a subject to obtain measurement data. The physiological measurements may be performed using a sensor system 5 as depicted schematically in
In step S2, measurement data obtained by performing the physiological measurements in step S1 is received by a data receiving unit 3. The data receiving unit 3 may form part of a computing system 2 (e.g. laptop computer, desktop computer, smart device, wearable smart device, etc.). The computing system 2 may further comprise a data processing unit 4 configured to carry out steps of the method.
In step S3, the measurement data is filtered to at least partially remove noise from the measurement data. The filtering may comprise applying a band-pass filter or low-pass filter. Alternatively, as described in further detail below, an adaptive line enhancer (ALE) may be applied to the measurement data. As depicted in
In step S4, a signal-to-noise ratio of the filtered measurement data in each channel 7A-C is obtained. In
In step S5, spectral analysis is performed to extract a frequency of a periodic physiological process of interest. In some embodiments of the present disclosure, the frequency of the periodic physiological process comprises a respiration rate (RR). Further details about the spectral analysis are given below.
In step S6, a determination is made based on the spectral analysis of step S5 about whether the received measurement data is such as to allow a reliable estimate of the frequency of the periodic physiological process to be obtained. If yes, the method continues to step S7, an output is provided representing the extracted frequency of the periodic physiological process for the received measurement data, and the method loops back to step S2 to receive a next unit of measurement data to be processed. If no, the method loops straight back to step S2 to receive a next unit of measurement data to be processed, without providing any output. This methodology thus advantageously reduces the extent to which unreliable readings of the frequency of the periodic physiological process are output.
As mentioned above, in some embodiments an adaptive line enhancer (ALE) is used to at least partially remove noise from measurement data. This process is now described in further detail.
The ALE, introduced in [8], has been used in many applications [9] for separation of a low level sinusoid or a narrow-band oscillation from broad-band noise. The core concept of the ALE is based on linear prediction where the nearly-periodic signal is believed to be perfectly predicted based on the past samples while a non-periodic signal cannot be predicted. A delayed version of the input signal is used as a reference signal into a least-mean-square (LMS) adaptive filter and the desired signal is considered as the original signal. An error signal of the LMS filter provides an estimate of the noise in the input signal and the output signal corresponds to the desired separated signal (i.e. separated from the noise). In specific examples of the present disclosure where it is desired to estimate RR using acceleration signals, the ALE can be applied to each accelerometer axis separately. The ratio of the power of signal to the power of noise provides a signal-to-noise ratio (SNR). The SNR can be used, as described above, to select an accelerometer axis to use in subsequent processing steps (e.g. an axis with the highest SNR is selected).
After selection of the desired accelerometer axis, Fast Fourier Transform (FFT) could be applied to estimate the highest peak amplitude of the spectrum of ALE signal output in the range of 0.05 Hz to 1 Hz. Then, a frequency with maximum peak amplitude could be obtained, which could correspond to the frequency of the periodic physiological process being monitored (e.g. respiration rate). However, it has been found that the frequency obtained in this way does not accurately reflect the underlying frequency of the periodic process in all situations. For some segments (units) of measurement data, multiple local maximum peaks in the spectral domain are observed, which makes discrimination of the physiological frequency difficult. Embodiments of the present disclosure use the following spectral analysis in step S5 of the method to improve reliability.
In some embodiments, the spectral analysis of step S5 comprises processing the measurement data to represent the measurement data as a mathematical expansion. The measurement data may thus be transformed by the processing of the measurement data, the transformation resulting in the measurement data being represented as a mathematical expansion. The mathematical expansion comprises a plurality of expansion components and a corresponding plurality of expansion coefficients. Each expansion coefficient represents the respective strength of each expansion component in the mathematical expansion. Thus, expansion components which contribute to the measurement data to a large extent will have a large expansion coefficient and expansion components which contribute to the measurement data to a smaller extent will have smaller expansion coefficients. In some embodiments, each expansion component comprises an eigenvector and each expansion coefficient comprises an eigenvalue. In some embodiments, the eigenvectors and eigenvalues are determined using singular spectrum analysis (SSA) [10]. It has been shown in [11] that after applying SSA into acceleration signals and using the resulting eigenvectors and their corresponding eigenvalues, it is possible to extract the trend of the data or the lowest possible dominant frequency (considering the largest eigenvalues) in the signals.
The inventors have found that by performing partial reconstructions of the measurement data using different combinations of the eigenvectors mentioned above, it is possible to extract the frequency of the physiological process being monitored more accurately and/or identify segments of measurement data from which it is not possible to obtain a reliable estimate of the frequency of the physiological process.
In an embodiment, a first partial reconstruction of the measurement data is formed using a first subset of the expansion components (e.g. eigenvectors) and corresponding expansion coefficients (e.g. eigenvalues). A second partial reconstruction of the measurement data is formed using a second subset of the expansion components (e.g. eigenvectors) and corresponding expansion coefficients (e.g. eigenvalues). The second subset is different from the first subset.
A first spectral analysis (e.g. using a fast Fourier transform, FFT) is then performed on the first partial reconstruction to determine a first dominant frequency. The first dominant frequency represents a frequency component of largest amplitude in the first partial reconstruction.
A second spectral analysis (e.g. using a fast Fourier transform, FFT) is performed on the second partial reconstruction to determine a second dominant frequency. The second dominant frequency represents a frequency component of largest amplitude in the second partial reconstruction.
The first and second partial reconstructions may be referred to respectively as sub-band1 and sub-band2. The provision of an output representing a frequency of a periodic physiological process of step S7 can be performed based on either or both of the first dominant frequency and the second dominant frequency. In a case where the measurement data is able to yield a reliable value for the physiological frequency of interest, the first dominant frequency and the second dominant frequency should both correspond closely to the physiological frequency (and not some other artefactual frequency present in the measurement data). The output may be obtained for example by taking an average of the first dominant frequency and the second dominant frequency, or simply by taking one or the other of the first dominant frequency and the second dominant frequency (as they are both similar).
The inventors have found that in cases where the measurement data is unable to yield a reliable value for the physiological frequency of interest, for example because there are several spectral peaks in the frequency range of interest, the situation can be detected automatically and reliably by detecting when the first dominant frequency and the second dominant frequency differ from each other to a significant extent (e.g. by more than a predetermined threshold amount). Based on this recognition, in some embodiments a degree of similarity between the first dominant frequency and the second dominant frequency is determined and the output representing the frequency of the periodic physiological process is selectively provided (i.e. provided or not provided) in step S7 depending on the determined degree of similarity. For example, the output is provided if the degree of similarity is determined to be higher than a predetermined threshold.
In some embodiments, the first subset of expansion components (corresponding to sub-band1) comprises the N components respectively having the N largest expansion coefficients. N may satisfy the following inequality: 2≤N≤5. In an embodiment, N=3. In an embodiment, the second subset of expansion components (corresponding to sub-band2) does not comprise the expansion component having the largest expansion coefficient. In an embodiment, the second subset of expansion components comprises the expansion components corresponding to the N largest expansion coefficients except the largest expansion coefficient. In an embodiment, the second subset of expansion components comprises the 2nd and 3rd largest.
In the detailed examples described below, the spectral analysis of step S5 was performed on measurement data to which ALE had been applied in step S3 and to an accelerometer axis selected using the ALE output in step S4 to decompose the measurement data into corresponding eigenvectors and eigenvalues. The eigenvectors were sorted in descending order of associated eigenvalues and grouped using a set of indices as {1,2,3} (denoting eigenvectors related to first, second, and third largest eigenvalues) and {2,3} (denoting eigenvectors related to the second and third largest eigenvalues). After grouping the eigenvectors into these two sub-bands (sub-band1 for {1,2,3} indices and sub-band2 for {2,3} indices), a final elementary matrix was formed by summation of all elementary matrices in each group. Diagonal averaging was applied to the final elementary matrix and a resulting signal formed for each group. For each sub-band, one narrowband signal was reconstructed (an example of the partial reconstruction referred to above). An FFT algorithm was then applied to each narrowband signal to estimate and compare the frequency spectrum for the two selected sub-bands.
The FFT was applied to each reconstructed signal corresponding to the sub-bands and the frequency with maximum peak amplitude was considered as a potential respiratory component. Then, for each sub-band, the RR was calculated as breaths per minute (based on the maximum peak). If the absolute difference in estimated RR from the two sub-bands was less than 4 bpm (an example of the predetermined threshold mentioned above), an average RR was used as the final estimated RR, otherwise, it was determined that a reliable RR could not be obtained from the measurement data (the “no” loop in
Waveform data were collected from voluntary participants in the Post Intensive Care Risk Alerting and Monitoring (PICRAM)—II trial. This waveform data was collected using continuous monitoring equipment provided by Hidalgo Ltd. with an attached transmittance photoplethysmograph sensor provided by Nonin Medical Inc. The data was collected at both the John Radcliffe and the Reading Berkshire hospital. In this research only the data collected at Oxford John Radcliffe was used for analysis.
Time-stamped observations for patients admitted to the ward at the John Radcliffe hospital were recorded within the experiment. The data corresponds to admissions between 2013 and 2014. Sampling frequencies were 256 Hz for an electrocardiogram (ECG), 75 Hz for a PPG, and 25 Hz for an accelerometer.
Ten patients (five male, five female) were selected from a larger dataset. These selected patients' age range was from 45 to 77 years old at the time of discharge from the ICU. The select patients' mean age was calculated as 63.7 years old. The length of their stay at the ICU ranged from 1 day to 15 days. The hospital length of stay for these patients ranged from 7 days to 47 days. All patients were white except one with black/British black ethnicity.
For estimation of RR from accelerometer signals, the ALE was applied to each axis of the accelerometer signal to separate the oscillatory and noise component of the accelerometer axes. A delay (δ) of 10 samples was used to generate the reference signal for the adaptive filter. The normalised least mean square (NLMS) adaptive filter with an order of (M=20), and an offset of (N=50) was applied. Units of measurement data were obtained by forming 64-second windowed data segments and discarding the first 16 seconds of each data segment. Each resulting 48-seconds long data segment corresponded to one unit of measurement data to be processed. A reduced window size of 48-seconds promotes convergence of the NLMS. The ALE separates the noise and signal component of each accelerometer axis.
Example 1:
Example 2:
Example 3:
Example 4:
Uniform acceleration signals are expected to provide clear spectra. By detailed examination of the acceleration signals, it is found that many types of motions, especially transient motion interferences not related to respiration, provide low frequency edges or artefacts in the accelerometer spectra. Examples of spectra containing such low frequency artefacts are shown in Examples 3 and 4 and it is described how our method provides sufficient sensitivity to extract the correct RR values and/or reliably recognise when a reading is probably invalid.
For the patients selected in this study, measurements of RR using a method of an embodiment were compared with measurements of RR obtained from PPG signals and measurements of RR recorded manually by nurses in an average of every 6 hours. The results of such a comparison are shown in
In Table I, for 10 selected patients, detailed statistics are provided. Based on this table, the number of PPG segments to estimate RR is shown in the second column for each subject. These segments are converted to their time duration in terms of the number of hours of recorded PPG data. Then, the number of segments with a PPG Signal Quality Index (SQI), indicated a quality of the signal for the segment in question, of greater than or equal to 0.85 is provided in the third column. The percentage of segments produced RR estimates based on smart fusion of PPG data (agreement of auto-regression, AR, spectrum in two modulations) are shown for each subject. For accelerometer-based estimation of RR, the initial number of segments of measurement data and the corresponding time duration in terms of the hours of data are provided. Also the percentage of obtained segments to estimate RR based on the spectral analysis approach involving agreement of sub-bands (as discussed above) is provided.
The time-stamps have been used to compare the errors of pairwise estimated RRs where both PPG and accelerometer-based RR estimates are available. The mean absolute error (MAE) is shown in the last column of Table I. As it can be seen from Table I, all the resulted MAEs are less than 2.60 bpm. It should be noted that the sample size to calculate the MAE is not the same for all the subjects. Meanwhile, very good MAEs have been achieved for most subjects (less than 2 bpm). The accelerometers have been able to produce RR estimates for about 70 hours of the continuous data while this has been recorded for about 27 hours of PPG data. Although after data fusion, for error measurements, the number of segments are reduced to consider highly reliable RR outputs of the algorithms.
Number | Date | Country | Kind |
---|---|---|---|
1803994.1 | Mar 2018 | GB | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/GB2019/050164 | 1/22/2019 | WO | 00 |